MX2021013725A - Butirato alimenticio y sus usos. - Google Patents

Butirato alimenticio y sus usos.

Info

Publication number
MX2021013725A
MX2021013725A MX2021013725A MX2021013725A MX2021013725A MX 2021013725 A MX2021013725 A MX 2021013725A MX 2021013725 A MX2021013725 A MX 2021013725A MX 2021013725 A MX2021013725 A MX 2021013725A MX 2021013725 A MX2021013725 A MX 2021013725A
Authority
MX
Mexico
Prior art keywords
dietary butyrate
bone growth
bone
carbons
promotion
Prior art date
Application number
MX2021013725A
Other languages
English (en)
Inventor
Amaury Patin
Marie Noëlle Horcajada
Elizabeth Forbes-Blom
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2021013725A publication Critical patent/MX2021013725A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Uso de un compuesto que tiene la fórmula (1), (2), (3) o (4), (ver Fórmulas) o combinaciones de estas, para usar en la promoción del crecimiento óseo y/o prevención y/o tratamiento de trastornos óseos asociados con el deterioro del crecimiento óseo, en donde R1, R2, R3, R4, R5 y R6 son independientemente un ácido graso de cadena larga que tiene entre 16 y 20 carbonos.
MX2021013725A 2019-05-21 2020-05-20 Butirato alimenticio y sus usos. MX2021013725A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19175533 2019-05-21
PCT/EP2020/064078 WO2020234354A1 (en) 2019-05-21 2020-05-20 Dietary butyrate and its uses

Publications (1)

Publication Number Publication Date
MX2021013725A true MX2021013725A (es) 2021-12-10

Family

ID=66655129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013725A MX2021013725A (es) 2019-05-21 2020-05-20 Butirato alimenticio y sus usos.

Country Status (7)

Country Link
US (1) US20220241236A1 (es)
EP (1) EP3972429A1 (es)
CN (1) CN113853123A (es)
AU (1) AU2020280899A1 (es)
BR (1) BR112021020909A2 (es)
MX (1) MX2021013725A (es)
WO (1) WO2020234354A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662953A (en) * 1989-09-20 1997-09-02 Nabisco, Inc. Reduced calorie triglyceride mixtures
ITFI20050024A1 (it) * 2005-02-14 2006-08-15 Fernando Cantini Lipidi per l'alimentazione degli animali
CN100344280C (zh) * 2005-08-01 2007-10-24 清华大学 3－羟基丁酸及其衍生物的新用途
IL184982A0 (en) * 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
US8206772B2 (en) * 2007-11-08 2012-06-26 Kraft Foods Global Brands Llc Structured lipid compositions and methods of formulation thereof
ES2559381T3 (es) * 2011-10-18 2016-02-11 Nestec S.A. Composición para su uso en la promoción del crecimiento de hueso sano y/o en la prevención y/o tratamiento de osteopatía
WO2013191533A1 (en) * 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
US20170127693A1 (en) * 2015-11-09 2017-05-11 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
CA3101629A1 (en) * 2018-06-01 2019-12-05 Societe Des Produits Nestle S.A. Dietary butyrate
US20220226273A1 (en) * 2019-05-21 2022-07-21 Societe Des Produits Nestle S.A. Dietary butyrate and its uses
WO2021110963A1 (en) * 2019-12-05 2021-06-10 Société des Produits Nestlé S.A. Dietary butyrate

Also Published As

Publication number Publication date
CN113853123A (zh) 2021-12-28
EP3972429A1 (en) 2022-03-30
BR112021020909A2 (pt) 2022-05-24
AU2020280899A1 (en) 2021-10-28
US20220241236A1 (en) 2022-08-04
WO2020234354A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
MX2018005925A (es) Purinonas como inhibidores de proteasa específica de ubiquitina 1.
JOP20220179A1 (ar) N4-هيدروكسي سيتيدين ومشتقات واستخدامات مضادة للفيروسات مرتبطة بها
PH12020551578A1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
MY145439A (en) Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
MX2019013561A (es) Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos.
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
TW200621765A (en) Substituted phenylaminothiazoles and their use
MX2020012344A (es) Butirato alimenticio.
WO2018153508A3 (en) INHIBITORS OF SULFOXIMINE GLYCOSIDASE
NO20082096L (no) Azaindol-2-karboksamidderivativer
GEP20247596B (en) Crystalline forms and salt forms of a kinase inhibitor
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
CA2902116C (en) Pyrrolopyridine derivatives and their use as inhibitors of ssao activity
MX2022003037A (es) Compuestos antibacterianos.
EP2215054B8 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
PH12020552162A1 (en) Thiophene derivatives for the treatment of disorders caused by ige
DE60335647D1 (de) Pyrroloquinoline quinone und ein betablocker zur behandlung von ischämie oder reperfusionsschäden
DE60232173D1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
MX2024001774A (es) Compuesto inductor de la degradacion de plk1 novedoso.
MX2023014530A (es) Nitroxolina para su uso en el tratamiento de neurofibroma cutaneo.
WO2023285654A3 (en) Compounds for the treatment of covid-19
MX2022005084A (es) Formas sólidas de un modulador del receptor s1p a.
WO2019109067A3 (en) Creatine prodrugs, compositions and methods of use thereof
MX2019013562A (es) Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos.